PubRank

Christian Joukhadar

Author PubWeight™ 57.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008 3.28
2 C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2007 1.79
3 In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging 2004 1.67
4 Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil. Epilepsia 2007 1.55
5 Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003 1.44
6 The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology 2006 1.40
7 AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res 2007 1.35
8 Principles of antibiotic penetration into abscess fluid. Pharmacology 2006 1.30
9 Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients. Eur J Nucl Med Mol Imaging 2007 1.25
10 Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles. Antimicrob Agents Chemother 2005 1.22
11 Daptomycin: a review 4 years after first approval. Pharmacology 2007 1.15
12 Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother 2010 1.15
13 High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother 2009 1.14
14 Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis 2005 1.12
15 Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother 2005 1.10
16 Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study. Nephrol Dial Transplant 2009 1.02
17 AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol 2007 1.01
18 Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections. Int J Antimicrob Agents 2010 1.00
19 Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology 2007 0.98
20 Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother 2006 0.96
21 Extracellular concentrations of fosfomycin in lung tissue of septic patients. J Antimicrob Chemother 2010 0.96
22 Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003 0.96
23 Efficacy and safety of current drug therapies for invasive aspergillosis. Pharmacology 2011 0.95
24 Effect of severity of sepsis on tissue concentrations of linezolid. J Antimicrob Chemother 2007 0.95
25 Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med 2002 0.94
26 The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem 2005 0.91
27 Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother 2005 0.91
28 Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). AAPS J 2005 0.90
29 Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother 2004 0.90
30 Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med 2005 0.90
31 Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis. Scand J Infect Dis 2008 0.87
32 A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther 2006 0.87
33 Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice. J Invest Dermatol 2007 0.86
34 Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis. Antimicrob Agents Chemother 2007 0.85
35 Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br J Clin Pharmacol 2004 0.84
36 Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. Clin Sci (Lond) 2003 0.84
37 The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 2004 0.83
38 Plasma and peritoneal dialysate levels during daptomycin therapy for peritonitis. Am J Kidney Dis 2009 0.83
39 A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. Int J Antimicrob Agents 2007 0.82
40 Daptomycin does not exert immunomodulatory effects in an experimental endotoxin model of human whole blood. Pharmacology 2007 0.82
41 The ability of fluconazole to penetrate into ventilated, healthy and inflamed lung tissue in a model of severe sepsis in rats. Pharmacology 2011 0.82
42 Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis. Clin Pharmacokinet 2007 0.81
43 Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers. Antimicrob Agents Chemother 2004 0.81
44 Development of a high-performance liquid chromatography method for the determination of caspofungin with amperometric detection and its application to in vitro microdialysis experiments. J Chromatogr B Analyt Technol Biomed Life Sci 2006 0.80
45 The effect of food on plasma and tissue concentrations of linezolid after multiple doses. Int J Antimicrob Agents 2006 0.79
46 Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Antimicrob Agents Chemother 2004 0.79
47 Immunomodulatory effects of fosfomycin in experimental human endotoxemia. Antimicrob Agents Chemother 2007 0.78
48 Immunomodulatory effects of fosfomycin in an endotoxin model in human blood. J Antimicrob Chemother 2006 0.78
49 Determination of fosfomycin in pus by capillary zone electrophoresis. J Chromatogr A 2005 0.78
50 Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects. J Antimicrob Chemother 2004 0.78
51 S-ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood. Pharmacology 2007 0.77
52 High extracellular levels of cefpirome in unaffected and infected lung tissue of patients. J Antimicrob Chemother 2010 0.77
53 Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int J Antimicrob Agents 2003 0.77
54 Multiple-dose pharmacokinetics of telithromycin in peripheral soft tissues. Int J Antimicrob Agents 2009 0.77
55 Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration. J Antimicrob Chemother 2006 0.77
56 Capillary electrophoresis analysis of fosfomycin in biological fluids for clinical pharmacokinetic studies. Electrophoresis 2004 0.77
57 Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. Pharmacology 2005 0.77
58 The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model. Wien Klin Wochenschr 2009 0.76
59 A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates. Clin Pharmacokinet 2011 0.76
60 Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother 2007 0.75
61 Wine ingestion has no effect on lipid peroxidation products. Pharmacology 2005 0.75
62 Glycerophosphate is interchangeable with inorganic phosphate in terms of safety and serum pharmacokinetics. Pharmacology 2011 0.75
63 Determination of telithromycin in human plasma and microdialysates by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2005 0.75
64 Is experimental endotoxaemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock? A pilot study using the model compound fosfomycin. Int J Antimicrob Agents 2007 0.75
65 Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice. Pharmacology 2008 0.75
66 Rapid and sensitive determination of the antibiotic linezolid in low plasma volumes by high-performance liquid chromatography. J Chromatogr Sci 2010 0.75
67 Tigecycline has no effect on cytokine release in an ex vivo endotoxin model of human whole blood. Int J Antimicrob Agents 2009 0.75
68 Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort. Wien Klin Wochenschr 2010 0.75
69 Urea as an endogenous surrogate in human microdialysis to determine relative recovery of drugs: analytics and applications. J Pharm Biomed Anal 2005 0.75
70 [Cytochrom-P450 mediated drug interactions caused by antibiotics]. Wien Med Wochenschr 2006 0.75
71 [Non-lipid effects of statins: myth or fact?]. Wien Med Wochenschr 2003 0.75
72 A bioequivalence study of two oral desmopressin tablet formulations. Pharmacology 2006 0.75
73 Glycerophosphate does not interact with components of parenteral nutrition. Pharmacology 2011 0.75